Henry Schein, Inc. (HSIC) EV/Sales Ratio: 0.95x
Is Henry Schein, Inc.’s EV/Sales ratio high or low?
Henry Schein, Inc.'s EV/Sales ratio of 0.95x is in line with its 5-year average of 0.95x, around the middle of its 5-year range (0.79x–1.18x).
As of Tuesday, June 23, 2026. 1.47% above its 12-month average of 0.94x.
HSIC EV/Sales Ratio Chart
HSIC Average EV/Sales Ratio Chart
HSIC Current vs Average EV/Sales Ratio Chart
HSIC EV/Sales Ratio Metrics
EV/SALES RATIO
0.95x
EV/SALES RATIO AVG TTM
0.94x
EV/SALES RATIO AVG 3Y
0.94x
EV/SALES RATIO AVG 5Y
0.95x
EV/SALES RATIO AVG 10Y
0.96x
EV/SALES RATIO AVG 15Y
0.93x
EV/SALES RATIO AVG 20Y
0.86x
CURRENT VS TTM AVG
+1.47%
CURRENT VS 3Y AVG
+1.20%
CURRENT VS 5Y AVG
+0.14%
CURRENT VS 10Y AVG
-1.13%
CURRENT VS 15Y AVG
+2.13%
CURRENT VS 20Y AVG
+10.51%
HSIC Competitors' EV/Sales Ratio
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Henry Schein, Inc. (HSIC) | $8.96B | 0.95x | 0.94x | 0.94x | 0.95x |
| Charles River Laboratories International, Inc. (CRL)vs › | $8.75B | 2.92x | 2.80x | 3.02x | 3.77x |
| Tempus AI, Inc. (TEM)vs › | $8.35B | 6.86x | 11.28x | 12.14x | 12.14x |
| Oscar Health, Inc. (OSCR)vs › | $7.63B | 0.38x | 0.23x | 0.31x | 0.45x |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.60B | 3.26x | 3.42x | 3.66x | 4.56x |
| Baxter International Inc. (BAX)vs › | $10.36B | 1.57x | 1.70x | 2.16x | 2.63x |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | 0.25x | 0.26x | 0.37x | 0.45x |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.48B | 3.62x | 4.59x | 4.20x | 4.23x |
| Revvity, Inc. (RVTY)vs › | $11.05B | 4.68x | 4.79x | 5.55x | 5.57x |
| Align Technology, Inc. (ALGN)vs › | $12.44B | 2.81x | 2.72x | 4.05x | 5.85x |
Understanding EV/Sales
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
- It works for unprofitable companies where P/E doesn't apply
- Revenue is harder to manipulate than earnings
- It supports comparisons across companies at different profitability stages
- It is frequently used for software and other revenue-growth-focused companies
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
Henry Schein, Inc. EV/Sales Ratio Formula & Definition
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Henry Schein, Inc. EV/Sales Ratio FAQ
- What is the EV/Sales ratio for Henry Schein, Inc. (HSIC)?
- The EV/Sales ratio for HSIC stock is 0.95x.
- Is Henry Schein, Inc.'s EV/Sales ratio high or low?
- Henry Schein, Inc.'s EV/Sales ratio of 0.95x is in line with its 5-year average of 0.95x, around the middle of its 5-year range (0.79x–1.18x).
- What is the TTM average EV/Sales ratio for Henry Schein, Inc. (HSIC)?
- The TTM average EV/Sales ratio for HSIC stock is 0.94x.
- What is the 3Y average EV/Sales ratio for Henry Schein, Inc. (HSIC)?
- The 3Y average EV/Sales ratio for HSIC stock is 0.94x.
- What is the 5Y average EV/Sales ratio for Henry Schein, Inc. (HSIC)?
- The 5Y average EV/Sales ratio for HSIC stock is 0.95x.
- What is the 10Y average EV/Sales ratio for Henry Schein, Inc. (HSIC)?
- The 10Y average EV/Sales ratio for HSIC stock is 0.96x.
- What is the 15Y average EV/Sales ratio for Henry Schein, Inc. (HSIC)?
- The 15Y average EV/Sales ratio for HSIC stock is 0.93x.
- What is the 20Y average EV/Sales ratio for Henry Schein, Inc. (HSIC)?
- The 20Y average EV/Sales ratio for HSIC stock is 0.86x.
Henry Schein, Inc. EV/Sales Ratio History
| DATE | EV/SALES RATIO |
|---|---|
| 2026-06-22 | 0.95x |
| 2026-06-18 | 0.96x |
| 2026-06-17 | 0.96x |
| 2026-06-16 | 0.97x |
| 2026-06-15 | 0.97x |
| 2026-06-12 | 0.97x |
| 2026-06-11 | 0.97x |
| 2026-06-10 | 0.95x |
| 2026-06-09 | 0.96x |
| 2026-06-08 | 0.95x |
| 2026-06-05 | 0.94x |
| 2026-06-04 | 0.93x |
| 2026-06-03 | 0.93x |
| 2026-06-02 | 0.93x |
| 2026-06-01 | 0.93x |
| 2026-05-29 | 0.93x |
| 2026-05-28 | 0.93x |
| 2026-05-27 | 0.93x |
| 2026-05-26 | 0.91x |
| 2026-05-22 | 0.91x |
| 2026-05-21 | 0.91x |
| 2026-05-20 | 0.90x |
| 2026-05-19 | 0.90x |
| 2026-05-18 | 0.90x |
| 2026-05-15 | 0.90x |
| 2026-05-14 | 0.90x |
| 2026-05-13 | 0.87x |
| 2026-05-12 | 0.87x |
| 2026-05-11 | 0.87x |
| 2026-05-08 | 0.88x |
| 2026-05-07 | 0.88x |
| 2026-05-06 | 0.90x |
| 2026-05-05 | 0.91x |
| 2026-05-04 | 0.91x |
| 2026-05-01 | 0.93x |
| 2026-04-30 | 0.94x |
| 2026-04-29 | 0.93x |
| 2026-04-28 | 0.95x |
| 2026-04-27 | 0.96x |
| 2026-04-24 | 0.96x |
| 2026-04-23 | 0.97x |
| 2026-04-22 | 0.97x |
| 2026-04-21 | 0.98x |
| 2026-04-20 | 0.98x |
| 2026-04-17 | 0.98x |
| 2026-04-16 | 0.96x |
| 2026-04-15 | 0.96x |
| 2026-04-14 | 0.96x |
| 2026-04-13 | 0.95x |
| 2026-04-10 | 0.94x |
| 2026-04-09 | 0.95x |
| 2026-04-08 | 0.95x |
| 2026-04-07 | 0.93x |
| 2026-04-06 | 0.94x |
| 2026-04-02 | 0.93x |
| 2026-04-01 | 0.92x |
| 2026-03-31 | 0.93x |
| 2026-03-30 | 0.92x |
| 2026-03-27 | 0.91x |
| 2026-03-26 | 0.93x |
| 2026-03-25 | 0.93x |
| 2026-03-24 | 0.93x |
| 2026-03-23 | 0.94x |
| 2026-03-20 | 0.92x |
| 2026-03-19 | 0.92x |
| 2026-03-18 | 0.92x |
| 2026-03-17 | 0.94x |
| 2026-03-16 | 0.94x |
| 2026-03-13 | 0.95x |
| 2026-03-12 | 0.94x |
| 2026-03-11 | 0.95x |
| 2026-03-10 | 0.95x |
| 2026-03-09 | 0.97x |
| 2026-03-06 | 0.96x |
| 2026-03-05 | 0.99x |
| 2026-03-04 | 0.99x |
| 2026-03-03 | 0.99x |
| 2026-03-02 | 1.00x |
| 2026-02-27 | 1.01x |
| 2026-02-26 | 1.00x |
| 2026-02-25 | 1.00x |
| 2026-02-24 | 1.02x |
| 2026-02-23 | 1.01x |
| 2026-02-20 | 1.00x |
| 2026-02-19 | 0.97x |
| 2026-02-18 | 0.99x |
| 2026-02-17 | 0.98x |
| 2026-02-13 | 0.99x |
| 2026-02-12 | 0.99x |
| 2026-02-11 | 1.02x |
| 2026-02-10 | 1.01x |
| 2026-02-09 | 1.00x |
| 2026-02-06 | 1.00x |
| 2026-02-05 | 0.98x |
| 2026-02-04 | 0.96x |
| 2026-02-03 | 0.94x |
| 2026-02-02 | 0.96x |
| 2026-01-30 | 0.96x |
| 2026-01-29 | 0.95x |
| 2026-01-28 | 0.96x |
| 2026-01-27 | 0.97x |
| 2026-01-26 | 0.98x |
| 2026-01-23 | 0.98x |
| 2026-01-22 | 0.99x |
| 2026-01-21 | 0.99x |
| 2026-01-20 | 0.98x |
| 2026-01-16 | 1.00x |
| 2026-01-15 | 0.99x |
| 2026-01-14 | 0.97x |
| 2026-01-13 | 0.96x |
| 2026-01-12 | 0.97x |
| 2026-01-09 | 0.98x |
| 2026-01-08 | 0.99x |
| 2026-01-07 | 0.99x |
| 2026-01-06 | 0.99x |
| 2026-01-05 | 0.99x |
| 2026-01-02 | 0.97x |
| 2025-12-31 | 0.96x |
| 2025-12-30 | 0.97x |
| 2025-12-29 | 0.97x |
| 2025-12-26 | 0.97x |
| 2025-12-24 | 0.97x |
| 2025-12-23 | 0.97x |
| 2025-12-22 | 0.98x |
| 2025-12-19 | 0.98x |
| 2025-12-18 | 0.98x |
| 2025-12-17 | 0.97x |
| 2025-12-16 | 0.98x |
| 2025-12-15 | 0.98x |
| 2025-12-12 | 0.97x |
| 2025-12-11 | 0.97x |
| 2025-12-10 | 0.97x |
| 2025-12-09 | 0.95x |
| 2025-12-08 | 0.94x |
| 2025-12-05 | 0.94x |
| 2025-12-04 | 0.94x |
| 2025-12-03 | 0.94x |
| 2025-12-02 | 0.93x |
| 2025-12-01 | 0.94x |
| 2025-11-28 | 0.95x |
| 2025-11-26 | 0.96x |
| 2025-11-25 | 0.96x |
| 2025-11-24 | 0.95x |
| 2025-11-21 | 0.94x |
| 2025-11-20 | 0.92x |
| 2025-11-19 | 0.92x |
| 2025-11-18 | 0.92x |
| 2025-11-17 | 0.92x |
| 2025-11-14 | 0.92x |
| 2025-11-13 | 0.94x |
| 2025-11-12 | 0.94x |
| 2025-11-11 | 0.94x |
| 2025-11-10 | 0.94x |
| 2025-11-07 | 0.93x |
| 2025-11-06 | 0.91x |
| 2025-11-05 | 0.93x |
| 2025-11-04 | 0.93x |
| 2025-11-03 | 0.87x |
| 2025-10-31 | 0.86x |
| 2025-10-30 | 0.86x |
| 2025-10-29 | 0.85x |
| 2025-10-28 | 0.86x |
| 2025-10-27 | 0.86x |
| 2025-10-24 | 0.86x |
| 2025-10-23 | 0.86x |
| 2025-10-22 | 0.86x |
| 2025-10-21 | 0.87x |
| 2025-10-20 | 0.87x |
| 2025-10-17 | 0.86x |
| 2025-10-16 | 0.85x |
| 2025-10-15 | 0.86x |
| 2025-10-14 | 0.86x |
| 2025-10-13 | 0.86x |
| 2025-10-10 | 0.86x |
| 2025-10-09 | 0.87x |
| 2025-10-08 | 0.87x |
| 2025-10-07 | 0.87x |
| 2025-10-06 | 0.89x |
| 2025-10-03 | 0.90x |
| 2025-10-02 | 0.89x |
| 2025-10-01 | 0.88x |
| 2025-09-30 | 0.89x |
| 2025-09-29 | 0.89x |
| 2025-09-26 | 0.89x |
| 2025-09-25 | 0.88x |
| 2025-09-24 | 0.90x |
| 2025-09-23 | 0.92x |
| 2025-09-22 | 0.90x |
| 2025-09-19 | 0.90x |
| 2025-09-18 | 0.91x |
| 2025-09-17 | 0.90x |
| 2025-09-16 | 0.91x |
| 2025-09-15 | 0.91x |
| 2025-09-12 | 0.91x |
| 2025-09-11 | 0.92x |
| 2025-09-10 | 0.90x |
| 2025-09-09 | 0.90x |
| 2025-09-08 | 0.90x |
| 2025-09-05 | 0.92x |
| 2025-09-04 | 0.90x |
| 2025-09-03 | 0.90x |
| 2025-09-02 | 0.91x |
| 2025-08-29 | 0.92x |
| 2025-08-28 | 0.91x |
| 2025-08-27 | 0.91x |
| 2025-08-26 | 0.91x |
| 2025-08-25 | 0.91x |
| 2025-08-22 | 0.92x |
| 2025-08-21 | 0.91x |
| 2025-08-20 | 0.91x |
| 2025-08-19 | 0.91x |
| 2025-08-18 | 0.90x |
| 2025-08-15 | 0.90x |
| 2025-08-14 | 0.90x |
| 2025-08-13 | 0.91x |
| 2025-08-12 | 0.90x |
| 2025-08-11 | 0.89x |
| 2025-08-08 | 0.88x |
| 2025-08-07 | 0.88x |
| 2025-08-06 | 0.89x |
| 2025-08-05 | 0.87x |
| 2025-08-04 | 0.93x |
| 2025-08-01 | 0.91x |
| 2025-07-31 | 0.91x |
| 2025-07-30 | 0.93x |
| 2025-07-29 | 0.93x |
| 2025-07-28 | 0.94x |
| 2025-07-25 | 0.95x |
| 2025-07-24 | 0.96x |
| 2025-07-23 | 0.98x |
| 2025-07-22 | 0.96x |
| 2025-07-21 | 0.93x |
| 2025-07-18 | 0.93x |
| 2025-07-17 | 0.93x |
| 2025-07-16 | 0.93x |
| 2025-07-15 | 0.94x |
| 2025-07-14 | 0.94x |
| 2025-07-11 | 0.97x |
| 2025-07-10 | 0.98x |
| 2025-07-09 | 0.98x |
| 2025-07-08 | 0.97x |
| 2025-07-07 | 0.97x |
| 2025-07-03 | 0.98x |
| 2025-07-02 | 0.98x |
| 2025-07-01 | 0.98x |
| 2025-06-30 | 0.96x |
| 2025-06-27 | 0.97x |
| 2025-06-26 | 0.97x |
| 2025-06-25 | 0.96x |
| 2025-06-24 | 0.96x |
| 2025-06-23 | 0.95x |
| 2025-06-20 | 0.95x |
| 2025-06-18 | 0.95x |
| 2025-06-17 | 0.94x |
| 2025-06-16 | 0.94x |
| 2025-06-13 | 0.94x |
| 2025-06-12 | 0.94x |
| 2025-06-11 | 0.95x |
| 2025-06-10 | 0.95x |
| 2025-06-09 | 0.94x |
Showing the most recent 260 of 5,030 data points. The chart above shows the full history.
Related Metrics
About Henry Schein, Inc.
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Andrea Albertini